Acadia Healthcare Company, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-1.10B | $255.6M | $-21.7M | $273.1M | $190.6M | $-672.1M | $108.9M | $-175.8M |
| Depreciation & Amortization | $189.2M | $149.6M | $132.3M | $117.8M | $106.7M | $95.3M | $87.9M | $80.3M |
| Depreciation | $189.2M | $149.6M | $132.3M | $117.8M | $106.7M | $95.3M | $87.9M | $80.3M |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $31.7M | $37.1M | $32.3M | $29.6M | $37.5M | $22.5M | $17.3M | $22.0M |
| Net Cash from Operating Activities | $131.9M | $129.7M | $462.3M | $380.6M | $374.5M | $658.8M | $332.9M | $414.1M |
| Investing Activities | ||||||||
| Capital Expenditures | $571.8M | $690.4M | $424.1M | $296.1M | $244.8M | $225.0M | $232.7M | $253.2M |
| Business Acquisitions | $8.2M | $53.6M | $349.0K | $9.5M | $139.0M | — | $44.9M | — |
| Net Cash from Investing Activities | $-556.2M | $-736.5M | $-397.2M | $-305.8M | $1.01B | $-281.8M | $-201.1M | $-361.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $50.0M | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $481.3M | $583.0M | $-62.7M | $-110.9M | $-1.64B | $-51.5M | $-61.6M | $-67.3M |
| Net Change in Cash | $56.9M | $-23.8M | $2.4M | $-36.2M | $-244.9M | $254.5M | $49.0M | $-16.8M |
| Free Cash Flow | $-439.9M | $-560.7M | $38.2M | $84.4M | $129.7M | $433.8M | $100.2M | $160.9M |